ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Concept Of Four Contract Program

May 29, 1981

CAP Issues Active Surveillance Guidance For Prostate Cancer

September 5, 2014

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983

Trial Combines Drugs Against Blood Vessel Formation

October 26, 2007

Older Patients Tolerate Chemo, Decline Due To Severe Toxicity

February 28, 2003

New Model Provides Better Estimate of Breast Cancer Risk in Black Women.

November 30, 2007